Researcher

    Gilles Hickson , Ph.D.

    gilles.hickson@umontreal.ca
    Gilles Hickson
    Research Axis
    Viral and Immune Disorders and Cancers
    Research Theme
    Cancer: genetic and molecular mechanisms, and new therapies
    Address
    CHUSJ

    Phone
    514 345-4931 #2189

    Fax
    514 345-4731

    Online

    Title

    • Associate Research Professor, Department of Pathology and Cell Biology, Université de Montréal

    Internship opportunity(ies)

    Education

    • Postdoctoral Fellow in Biochemistry and Biophysics, University of California, San Francisco, 2002-2009.
    • PhD in Cell Biology, University of Glasgow, Scotland, United Kingdom, 1998-2001.
    • BSc (Hons) in Biology and French, University of Manchester, United Kingdom, 1993-1998.

    Research Interests

    Molecular mechanisms of cytokinesis

    Cell division is a fundamental and universal process that is essential for all development. It occurs in a two-step process: first, during mitosis, duplicated sets of chromosomes move to opposite poles of the cell; second, during cytokinesis, the cell physically splits into two cells each containing one set of chromosomes. Scientists have been observing cytokinesis for over a century and have long proposed that defects in the process give rise to cancer. However, we are only beginning to understand how cytokinesis is regulated at the molecular level.

    The long-term aim of our lab is to understand how cytokinesis normally occurs, and how its dysfunction can promote cancer. Ultimately, this will lead to better cancer treatments.

    Cytokinesis requires the formation of a dynamic actin- and myosin-based structure, the contractile ring, which forms beneath the plasma membrane at the cell equator during anaphase. Constriction of this ring pulls the plasma membrane into the cell interior during cleavage furrow ingression. The contractile ring then hands over the job of holding the plasma membrane to another more stable structure called the midbody ring, which is where the plasma membrane must ultimately pinch off to generate two distinct cells. Our current research efforts are centered on understanding how the midbody ring derives from the contractile ring, as we know very little about this process which is vital to the success of cytokinesis.

    We use cultured cells from the fruitfly, Drosophila melanogaster, as a model system. These cells are extremely sensitive to RNA interference, allowing us to inactivate genes at will. Previously, this allowed us to define the set of genes required for cytokinesis in a genome-wide RNAi screen. S2 cells are also ideally suited to high-resolution video-microscopy and are easily transfected to generate stable lines expressing fluorescent versions of proteins of interest. Using this system, we have uncovered many important insights into how cytokinesis is regulated.

    Developmental control of cytokinesis

    Although all cells divide by cytokinesis, they do not all do so in the same manner in the context of a developing organism. For example, a stem cell divides asymmetrically to ensure that one of the daughter cells remains a stem cell while the other follows its appropriate developmental fate.

    We would like to understand how the core cytokinetic machinery is differentially regulated to suit the needs of different developmental contexts. There exist many developmentally regulated variations of cytokinesis and these are particularly well described in Drosophila. We are beginning to explore cytokinesis in these in vivo contexts using high-resolution microscopy and the powerful genetic tools available for Drosophila.

    Awards and Distinctions

    • Junior 2 Research Scholar, Fonds de la recherche en santé du Québec, 2014-2017
    • Finalist for the 2014 Maud Menten New Principal Investigator Prize from the Canadian Institutes of Health Research – Institute of Genetics (CIHR-IG) in the biomedical research category
    • Transition Grant, Cole Foundation, 2013-2014.
    • Junior 1 Research Scholar, Fonds de la recherche en santé du Québec, 2010-2013.
    • Special Fellow, Leukemia & Lymphoma Society, 2007-2010.
    • Postdoctoral Fellow, Susan G. Komen for the Cure, 2004-2007.
About this page
Edited by Hoffmann Maude

Created on 9/18/2014
Alert or send a suggestion

Every dollar counts!

Thank you for your generosity.

It's people like you that allow us to accelerate research and heal more children better every year and, as such, offer among the best healthcare in the world.

It's also possible to give by mail or by calling toll-free

1-888-235-DONS (3667)

Contact Us

514 345-4931

Légal

© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security

Avertissement

Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine